GEODE CAPITAL MANAGEMENT, LLC
Position in CRVS — Corvus Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in CRVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$27,693,664
+$2,636,264 QoQ
Shares Held
1,853,659
+8.2% QoQ
Ownership
2.20%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,496,892 across 520 Biotechnology names. CRVS ranks #114 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in CRVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,693,664 | 1,853,659 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $25,057,400 | 1,712,741 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $11,342,300 | 1,473,026 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $10,734,610 | 1,456,528 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $5,446,960 | 1,361,740 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,877,108 | 590,286 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,032,716 | 566,863 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,972,686 | 563,009 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $837,454 | 460,140 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $661,738 | 371,763 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $634,268 | 360,380 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $526,154 | 360,380 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $783,360 | 342,079 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $270,998 | 297,800 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $253,130 | 297,800 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $244,438 | 298,460 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $295,475 | 298,460 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $489,474 | 298,460 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $686,546 | 284,874 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,017,576 | 210,243 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $506,074 | 189,541 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $458,408 | 148,834 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $393,949 | 110,660 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $447,307 | 111,548 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $392,664 | 144,362 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $293,112 | 138,916 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||